1. Novo Nordisk to acquire Emisphere Technologies

    and obtain ownership of the Eligen® SNAC oral delivery technology

  2. COVID-19 & diabetes

    If you have questions about physical and mental concerns during COVID-19, click the link below.

  3. Driving change

    We drive change to defeat diabetes and other serious chronic diseases.

  4. COVID-19 & obesity

    If you live with obesity, staying home for a prolonged period can make weight management difficult.


Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Roshi has type 1 diabetes and lives in India.

Annual Report 2019

Download Annual Report

Novo Nordisk Headquarters in Denmark.